Roxadustat and thyroid-stimulating hormone suppression

Hypoxia-inducible factor prolyl-hydroxylase inhibitors belong to a new class of orally administered drugs for treating anemia in patients with chronic kidney disease (CKD). The prevalence of hypothyroidism is disproportionately high in patients with CKD on hemodialysis. We report a rapid suppression...

Full description

Saved in:
Bibliographic Details
Published in:Clin Kidney J
Main Authors: Tokuyama, Atsuyuki, Kadoya, Hiroyuki, Obata, Atsushi, Obata, Takahiro, Sasaki, Tamaki, Kashihara, Naoki
Format: Artigo
Language:Inglês
Published: Oxford University Press 2021
Subjects:
Exceptional Cases
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8087136/
https://ncbi.nlm.nih.gov/pubmed/33959275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfab007
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items